Wellness · Medical Weight Loss

Tirzepatide for weight loss in Houston

Medically supervised tirzepatide (Zepbound™, Mounjaro®) evaluation at NeuMed Houston — dual GIP/GLP-1 therapy for eligible adults when clinically appropriate.

Using insurance? Check accepted plans · Paying out of pocket? View self-pay pricing

Tirzepatide weight loss treatment at NeuMed Houston

Tirzepatide at NeuMed

Tirzepatide is a dual GIP and GLP-1 receptor agonist approved for chronic weight management in eligible adults (Zepbound™) and type 2 diabetes (Mounjaro®). It may reduce appetite and support weight loss when combined with lifestyle changes — individual response varies.

NeuMed provides physician-led evaluation, monitoring, and follow-up at Houston-area clinics. Prescription requires consultation; not all patients are candidates.

Evaluation and candidacy

Before starting tirzepatide, a NeuMed provider reviews:

BMI and weight-related health conditions
Medical history — including thyroid disease, pancreatitis history, and pregnancy
Current medications
Baseline labs when clinically indicated

Monitoring and side effects

Common side effects include nausea, vomiting, diarrhea, and constipation — often most noticeable during dose escalation. Gradual titration and follow-up visits help manage tolerability.

Report severe abdominal pain or persistent vomiting promptly. Do not adjust dose without provider guidance.

Semaglutide vs tirzepatide

Both are GLP-1 class options with different mechanisms. Your NeuMed provider helps determine whether tirzepatide, semaglutide, or a non-medication approach fits your health profile.

Compare GLP-1 options

Self-pay pricing snapshot

Medical Weight Loss — member and non-member rates on our pricing page.

Full pricing
  • Iron Consulation $139
  • Semaglutide Consultation Bundle $249
  • Tirzepatide Consultation Bundle $269
  • Weight Loss Consult $199

Prices may vary. Insurance coverage depends on your plan — see our insurance page for accepted carriers.

Good to know

Frequently asked questions.

Is tirzepatide the same as Mounjaro or Zepbound?

Tirzepatide is the active ingredient. Mounjaro® is approved for type 2 diabetes; Zepbound™ is approved for chronic weight management. Your provider discusses appropriate use based on your evaluation.

Is tirzepatide better than semaglutide?

Clinical trials differ in design and population. The best choice depends on your health history, tolerance, insurance coverage, and clinical judgment — not universal superiority of one drug.

How do I get started with tirzepatide at NeuMed?

Book a medical weight loss consultation. Your provider assesses candidacy before any prescription is written.

Specials